Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The study is designed to determine the effects of an investigational drug Monofer in subjects
with non-dialysis dependent chronic kidney disease (NDD-CKD) subjects and with iron
deficiency anaemia (IDA).